You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 164 No. 15, August 9/23, 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Pathology & Laboratory Medicine
 •Alert me on articles by topic

Antiphospholipid Testing and Outcome—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

We appreciate Drs Pechlaner and Wiedermann's interest in our article1 as well as their provocative clinical questions. Our work focused on establishing the impact of APS in the natural history of systemic lupus erythematosus (SLE). Thus we did not analyze the utility of aPL assay in predicting an adverse outcome before the development of APS, although this would be certainly relevant for clinicians looking after patients with lupus.

The great variability of different tests to detect aPL is well known. Even more, SLE activity may induce transient positivity of aPL. However, all our patients with aPL had at least 2 positive determinations—this was our working definition for aPL positivity—and most of them had more than 2. Our aim was to identify those patients whose antibodies had a real pathogenic potential.

If we analyze 15-year survival rates according to aPL status, there is a trend toward decreased survival in . . . [Full Text of this Article]

Guillermo Ruiz-Irastorza, MD, PhD; Maria-Victoria Egurbide, MD; Ciriaco Aguirre, MD, PhD

Correspondence: Dr Ruiz-Irastorza, Servicio De Medicina Interna, Hospital De Cruces, Universidad Del Pais Vasco-Euskal Herriko, Unibertsitatea, 48903 Bizkaia, Spain (r.irastorza@euskalnet.net).


RELATED ARTICLES

Antiphospholipid Testing and Outcome
Christoph Pechlaner and Christian J. Wiedermann
Arch Intern Med. 2004;164(15):1701.
EXTRACT | FULL TEXT  

High Impact of Antiphospholipid Syndrome on Irreversible Organ Damage and Survival of Patients With Systemic Lupus Erythematosus
Guillermo Ruiz-Irastorza, Maria-Victoria Egurbide, Jon Ugalde, and Ciriaco Aguirre
Arch Intern Med. 2004;164(1):77-82.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Urinary tract infections in general practice patients: diagnostic tests versus bacteriological culture
Nys et al.
J Antimicrob Chemother 2006;57:955-958.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.